BLCM logo

Bellicum Pharmaceuticals (BLCM) Cash From Operations

Annual CFO

-$25.78 M
-$2.68 M-11.59%

December 31, 2022

Summary

Performance

1-Year Change

-11.59%

3-Year Change

+66.76%

5-Year Change

+64.67%

15-Year Change

+64.67%

BLCM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.61 M

3-Year Low

-$25.78 M
BLCM annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLCM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLCM next annual earnings announcement has not yet been scheduled

OtherBLCMcash flowmetrics:

Annual CFI

-$21.00 K
BLCM annual cash flow from investing activities is -$21.00 thousand

Annual CFF

$0.00
BLCM annual cash flow from financing activities is $0.00

Annual FCF

-$25.80 M
BLCM annual free cash flow is -$25.80 million

Annual CAPEX

$21.00 K
BLCM annual capital expenditures is $21.00 thousand

Quarterly CFO

-$1.52 M
+$6.48 M+81.03%

September 1, 2023

Summary

Performance

3-Month Change

+81.03%

1-Year Change

+74.33%

3-Year Change

+88.16%

5-Year Change

+90.91%

BLCM Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$948.00 K

3-Year Low

-$7.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
BLCM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
BLCM next earnings announcement has not yet been scheduled

OtherBLCMcash flowmetrics:

Quarterly CFI

$15.00 K
BLCM quarterly cash flow from investing activities is $15.00 thousand

Quarterly CFF

-
BLCM quarterly cash flow from financing activities value is unknown

Quarterly FCF

-$1.52 M
BLCM quarterly free cash flow is -$1.52 million

Quarterly CAPEX

$0.00
BLCM quarterly capital expenditures is $0.00

TTM CFO

-$22.85 M
+$4.39 M+16.11%

September 1, 2023

Summary

Performance

3-Month Change

+16.11%

1-Year Change

+8.23%

3-Year Change

+59.2%

5-Year Change

+70.54%

BLCM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$3.22 M

3-Year Low

-$27.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
BLCM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
BLCM next earnings announcement has not yet been scheduled

OtherBLCMcash flowmetrics:

TTM CFI

$4000.00
BLCM TTM cash flow from investing activities is $4000.00

TTM CFF

-
BLCM TTM cash flow from financing activities value is unknown

TTM FCF

-$22.86 M
BLCM TTM free cash flow is -$22.86 million

TTM CAPEX

$11.00 K
BLCM TTM capital expenditures is $11.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BLCM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.6%+74.3%+8.2%
3 y3 years+66.8%+88.2%+59.2%
5 y5 years+64.7%+90.9%+70.5%

BLCM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+11.6%at lowat high+427.2%+14.3%+19.2%
5 y5-year+11.6%+200.9%+52.2%+972.2%+14.3%+239.5%
alltimeall time+238.7%+200.9%+59.9%+3208.0%+610.1%+273.0%

Bellicum Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2023
-
-$1.52 M(-81.0%)
-$22.85 M(-16.1%)
Jun 2023
-
-$7.99 M(+24.3%)
-$27.24 M(+5.4%)
Mar 2023
-
-$6.43 M(-7.0%)
-$25.84 M(+0.2%)
Dec 2022
-$25.78 M(+11.6%)
-$6.91 M(+17.0%)
-$25.78 M(+3.5%)
Sep 2022
-
-$5.91 M(-10.4%)
-$24.90 M(+24.6%)
Jun 2022
-
-$6.59 M(+3.3%)
-$19.99 M(-5.7%)
Mar 2022
-
-$6.38 M(+5.8%)
-$21.19 M(-8.3%)
Dec 2021
-$23.11 M(-59.2%)
-$6.03 M(+505.2%)
-$23.11 M(-24.1%)
Sep 2021
-
-$996.00 K(-87.2%)
-$30.45 M(-27.9%)
Jun 2021
-
-$7.79 M(-6.1%)
-$42.26 M(-13.2%)
Mar 2021
-
-$8.29 M(-38.0%)
-$48.69 M(-14.1%)
Dec 2020
-$56.65 M(-27.0%)
-$13.38 M(+4.4%)
-$56.65 M(+1.1%)
Sep 2020
-
-$12.81 M(-9.9%)
-$56.01 M(-9.6%)
Jun 2020
-
-$14.21 M(-12.6%)
-$61.99 M(-10.5%)
Mar 2020
-
-$16.25 M(+27.7%)
-$69.27 M(-10.7%)
Dec 2019
-$77.57 M(+3.7%)
-$12.73 M(-32.2%)
-$77.57 M(-9.0%)
Sep 2019
-
-$18.79 M(-12.6%)
-$85.24 M(+2.5%)
Jun 2019
-
-$21.49 M(-12.5%)
-$83.13 M(+3.1%)
Mar 2019
-
-$24.56 M(+20.4%)
-$80.67 M(+7.9%)
Dec 2018
-$74.78 M
-$20.40 M(+22.3%)
-$74.78 M(+11.3%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$16.68 M(-12.3%)
-$67.20 M(-1.3%)
Jun 2018
-
-$19.03 M(+1.9%)
-$68.06 M(-1.7%)
Mar 2018
-
-$18.67 M(+45.6%)
-$69.20 M(-5.2%)
Dec 2017
-$72.98 M(+44.7%)
-$12.82 M(-26.9%)
-$72.98 M(-2.2%)
Sep 2017
-
-$17.54 M(-13.1%)
-$74.65 M(+9.0%)
Jun 2017
-
-$20.17 M(-10.2%)
-$68.51 M(+11.1%)
Mar 2017
-
-$22.45 M(+55.0%)
-$61.66 M(+22.2%)
Dec 2016
-$50.44 M(+41.2%)
-$14.49 M(+27.1%)
-$50.44 M(+4.9%)
Sep 2016
-
-$11.40 M(-14.4%)
-$48.09 M(+9.0%)
Jun 2016
-
-$13.31 M(+18.5%)
-$44.13 M(+10.5%)
Mar 2016
-
-$11.24 M(-7.4%)
-$39.94 M(+11.8%)
Dec 2015
-$35.73 M(-37.7%)
-$12.14 M(+63.1%)
-$35.73 M(-51.6%)
Sep 2015
-
-$7.44 M(-18.5%)
-$73.74 M(+9.7%)
Jun 2015
-
-$9.13 M(+29.9%)
-$67.25 M(+10.0%)
Mar 2015
-
-$7.03 M(-86.0%)
-$61.12 M(+6.6%)
Dec 2014
-$57.31 M(+652.9%)
-$50.15 M(+5190.1%)
-$57.31 M(+700.6%)
Sep 2014
-
-$948.00 K(-68.3%)
-$7.16 M(+15.3%)
Jun 2014
-
-$2.99 M(-7.0%)
-$6.21 M(+93.0%)
Mar 2014
-
-$3.22 M
-$3.22 M
Dec 2013
-$7.61 M(-1.7%)
-
-
Dec 2012
-$7.74 M
-
-

FAQ

  • What is Bellicum Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals annual CFO year-on-year change?
  • What is Bellicum Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals quarterly CFO year-on-year change?
  • What is Bellicum Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals TTM CFO year-on-year change?

What is Bellicum Pharmaceuticals annual cash flow from operations?

The current annual CFO of BLCM is -$25.78 M

What is the all time high annual CFO for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high annual cash flow from operations is -$7.61 M

What is Bellicum Pharmaceuticals annual CFO year-on-year change?

Over the past year, BLCM annual cash flow from operations has changed by -$2.68 M (-11.59%)

What is Bellicum Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of BLCM is -$1.52 M

What is the all time high quarterly CFO for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high quarterly cash flow from operations is -$948.00 K

What is Bellicum Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, BLCM quarterly cash flow from operations has changed by +$4.39 M (+74.33%)

What is Bellicum Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of BLCM is -$22.85 M

What is the all time high TTM CFO for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high TTM cash flow from operations is -$3.22 M

What is Bellicum Pharmaceuticals TTM CFO year-on-year change?

Over the past year, BLCM TTM cash flow from operations has changed by +$2.05 M (+8.23%)